methamphetamine has been researched along with Memory Disorders in 79 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.27) | 18.2507 |
| 2000's | 20 (25.32) | 29.6817 |
| 2010's | 40 (50.63) | 24.3611 |
| 2020's | 18 (22.78) | 2.80 |
| Authors | Studies |
|---|---|
| Benya-Aphikul, H; Chetprayoon, P; Pongrakhananon, V; Rodsiri, R; Sooksawate, T | 1 |
| Andrejewski, T; Aslan, A; Avila, JA; Luine, VN; Memos, N; Serrano, PA | 1 |
| Alizamini, MM; Haghparast, A; Li, Y; Liang, J; Zhang, JJ | 1 |
| Ahmadiani, A; Beirami, E; Dargahi, L; Heravi, M; Tamijani, SMS; Valian, N | 1 |
| Liang, Z; Lin, K; Ru, Q; Tian, X; Xiong, Q; Xu, C; Zeng, Q; Zhou, M | 1 |
| Asadi-Shekaari, M; Askari, R; Haghighi, AH; Keyhani, A; Nabavizadeh, MS; Shafiei, A | 1 |
| Garmabi, B; Khaksari, M; Khastar, H; Mohaddes, R; Mohseni, F; Rezvani, F | 1 |
| Arai, T; Matsumoto, M; Yamazaki, M; Yarimizu, J | 1 |
| Carter, JS; Denton, AR; Freels, DL; Goldsmith, ST; Hopkins, JL; Lewandowski, SI; Nelson, KH; Reichel, CM; Scofield, MD; Siemsen, BM; Wood, SK | 1 |
| Abdollahifar, MA; Aliaghaei, A; Anarkooli, IJ; Barfi, E; Boroujeni, ME; Fridoni, MJ; Golsorkhdan, SA; Nejatbakhsh, R; Ramezanpour, A | 1 |
| Haghparast, A; Mehdizadeh, M; Razavi, Y; Shabani, R | 1 |
| Burzynski, C; Cadet, JL; Gardner, EL; Jayanthi, S; Keck, TM; Ladenheim, B; Newman, AH; Schweppe, CA; van Praag, H; Xi, ZX | 1 |
| Baygi, F; Khosravi, B; Mansourian, M; Mirzaei, A; Qorbani, M; Rastegarimehr, B; Safari, O; Yoosefi Lebni, J; Ziapour, A | 1 |
| Huckans, M; Hudson, R; Lattal, KM; Loftis, JM; Navis, T; Person, U; Shirley, R; Taylor, J; Vandenbark, AA | 1 |
| Chancharoen, P; Govitrapong, P; Lwin, T; Mukda, S; Ngampramuan, S; Pinyomahakul, J; Rungruang, S; Veschsanit, N; Viwatpinyo, K; Yang, JL | 1 |
| Li, Y; Ru, Q; Shu, X; Tian, X; Xiong, Q; Yue, K; Zeng, Q; Zhou, M | 1 |
| Fan, Y; Ge, F; Guan, X; He, T; Li, N; Lu, X; Nie, J; Shi, P; Xu, X; Yu, P | 1 |
| Govitrapong, P; Namyen, J; Nopparat, C; Panmak, P; Permpoonpattana, K | 1 |
| Bernardi, A; Bisagno, V; Cadet, JL; García-Rill, E; Gomez, N; González, B; Jayanthi, S; Sosa, MH; Torres, OV; Urbano, FJ | 1 |
| Gutierrez, A; Vorhees, CV; Williams, MT | 1 |
| Cao, G; Chen, T; Chen, Y; Dang, Y; Dong, N; Zhang, Y; Zhao, N; Zhu, J; Zhu, L | 1 |
| Cho, EH; Jang, CG; Jeong, JH; Kim, HC; Kim, NH; Mai, HN; Nabeshima, T; Nah, SY; Nguyen, BT; Nguyen, PT; Sharma, N; Shin, EJ | 1 |
| Berman, NEJ; Chaudhari, NS; Glazyrin, A; Kumar, A; Nookala, AR; Schwartz, DC; Stephens, EB | 1 |
| Peters, J; Reichel, CM; Scofield, MD | 1 |
| Cadet, JL; Dang, DK; Hwang, YG; Jang, CG; Jeong, JH; Kim, HC; Nabeshima, T; Nah, SY; Sharma, N; Shin, EJ; Tran, HQ; Yoneda, Y | 1 |
| Gutierrez, A; Hoover, CS; Regan, SL; Vorhees, CV; Williams, MT | 1 |
| Ahmadiani, A; Beirami, E; Dargahi, L; Seyedhosseini Tamijani, SM | 1 |
| Chen, L; Gong, X; Li, C; Ru, Q; Si, Y; Xiao, H; Xiong, Q; Zhou, M | 1 |
| Huckans, M; Loftis, JM; Vandenbark, AA; Wilhelm, CJ | 1 |
| Jenner, P; Kadowaki Horita, T; Kanda, T; Kobayashi, M; Mori, A | 1 |
| Allen, CN; Belknap, JK; Derkach, VA; Olsen, RH; Phillips, TJ; Raber, J | 1 |
| Gilstrap, MG; Ramsey, LA; Reichel, CM; See, RE | 1 |
| Bisagno, V; Cadet, JL; García-Rill, E; González, B; Raineri, M; Urbano, FJ | 1 |
| Casaletto, KB; Franklin, DR; Grant, I; Morgan, EE; Obermeit, L; Weber, E; Woods, SP | 1 |
| Camarasa, J; Escubedo, E; López-Arnau, R; Martínez-Clemente, J; Pubill, D | 1 |
| Harper, DN; Harrow, CC; Macaskill, AC | 1 |
| Janetsian, SS; Lapish, CC; Linsenbardt, DN | 1 |
| Leong, KC; Peters, J; Reichel, CM; Schwendt, M; Scofield, MD; See, RE; Trantham-Davidson, H | 1 |
| Fleckenstein, AE; Hanson, GR; McFadden, LM; Nielsen, SM; Smith, MD; Vieira-Brock, PL | 1 |
| Bernheim, A; Reichel, CM; See, RE | 1 |
| Blouin, AM; Briggs, SB; Miller, CA; Rumbaugh, G; Young, EJ | 1 |
| Dai, H; Jia, F; Kato, M; Mobarakeh, JI; Okamura, N; Okuda, T; Sakurai, E; Takahashi, K; Xu, A; Yanai, K | 1 |
| Henry, JD; Mazur, M; Rendell, PG | 1 |
| Cook, IA; De la Garza, R; Green, MF; Kalechstein, AD; Leuchter, AF; Newton, TF | 1 |
| Ikejima, T; Kim, HC; Lu, L; Lu, P; Mamiya, T; Mouri, A; Nabeshima, T; Nagai, T; Niwa, M; Yamada, K; Zou, LB | 1 |
| Cordova, X; Dean, AC; London, ED; Monterosso, JR; Simon, SL | 1 |
| Nagai, T; Yamada, K | 1 |
| Camarasa, J; Escubedo, E; Pubill, D; Rodrigo, T | 1 |
| Chang, Y; Kim, YT; Kwon, DH | 1 |
| McGinty, JF; Olive, MF; Reichel, CM; Schwendt, M; See, RE | 1 |
| Ibi, D; Kamei, H; Mizoguchi, H; Nagai, T; Sato, J; Takase, F; Takuma, K; Toth, E; Yamada, K | 1 |
| Grant, I; Iudicello, JE; Weber, E; Weinborn, M; Woods, SP | 1 |
| Schilt, T; van Holst, RJ | 1 |
| Chavez, G; Edwards, S; George, O; Grant, Y; Kim, A; Koob, GF; Mandyam, CD; Recinto, P; Samant, AR; Soleiman, M; Wee, S; Yuan, CJ | 1 |
| Curran, HV; Freeman, TP; Hussain, N; Karimi, K; Morgan, CJ; Vaughn-Jones, J | 1 |
| Alves, CJ; de Sousa, L; Magalhães, A; Melo, P; Moradas-Ferreira, P; Summavielle, T; Tavares, MA | 1 |
| Chan, CH; Ghee, SM; Reichel, CM; See, RE | 1 |
| Hansen, R; Kaushal, N; Matsumoto, RR; McCurdy, CR; Seminerio, MJ; Zhang, HT | 1 |
| Callaghan, PD; Hicks, C; Karanges, E; Kendig, MD; Li, KM; McGregor, IS; Motbey, CP; Ramsay, J; Wilkinson, S; Winstock, AR; Wyatt, N | 1 |
| Baptista, S; Fontes-Ribeiro, C; Gonçalves, J; Malva, JO; Olesen, MV; Silva, AP; Woldbye, DP | 1 |
| den Hollander, B; Korpi, ER; Linden, AM; Ojanperä, I; Rozov, S; Uusi-Oukari, M | 1 |
| Boonchoong, P; Kammasud, N; Sumanont, Y; Vajragupta, O; Watanabe, H; Wongkrajang, Y | 1 |
| Marshall, JF; O'Dell, SJ; Schröder, N | 1 |
| Geaga, JA; Hayashi, KM; Hong, MS; Lee, JY; Ling, W; London, ED; Simon, SL; Sui, Y; Thompson, PM; Toga, AW | 1 |
| Belcher, AM; Marshall, JF; O'Dell, SJ | 1 |
| Mancusková, M; Pometlová, M; Slamberová, R; Syllabová, L | 1 |
| Kamei, H; Kobayashi, K; Maeda, K; Nabeshima, T; Nagai, T; Nakano, H; Takahashi, K; Takayanagi, M; Takuma, K; Togan, Y; Yamada, K; Yoshida, S | 1 |
| He, J; Li, X; Li, XM; Yang, Y; Yu, Y | 1 |
| Adame, A; Chana, G; Cherner, M; Crews, L; Ellis, R; Everall, IP; Grant, I; Heaton, R; Langford, D; Lazzaretto, D; Masliah, E | 1 |
| Do, KS; Kim, D; Moon, M; Park, J | 1 |
| Dohniwa, M; Ibi, D; Kamei, H; Mizoguchi, H; Nabeshima, T; Nagai, T; Takuma, K; Yamada, K | 1 |
| Schaefer, TL; Skelton, MR; Vorhees, CV; Williams, MT | 1 |
| Skelton, MR; Vorhees, CV; Williams, MT | 1 |
| Fukakusa, A; Ibi, D; Ito, Y; Kim, HC; Mizoguchi, H; Nakatani, A; Takuma, K; Yamada, K | 1 |
| Borges, F; Grade, S; Macedo, TR; Marques, E; Milhazes, N; Pereira, FC; Ribeiro, CF; Silva, AP; Simões, PF | 1 |
| Broening, HW; Fukumura, M; Inman-Wood, SL; Moran, MS; Morford, LL; Vorhees, CV | 1 |
| Monthakantirat, O; Peungvicha, P; Vajragupta, O; Watanabe, H; Wongkrajang, Y | 1 |
| Domier, CP; Ling, W; Rawson, RA; Richardson, K; Sim, T; Simon, SL | 1 |
| Maeda, N; Matsuoka, N; Ohkubo, Y; Yamaguchi, I; Yamazaki, M | 1 |
5 review(s) available for methamphetamine and Memory Disorders
| Article | Year |
|---|---|
Endocannabinoids and addiction memory: Relevance to methamphetamine/morphine abuse.
Topics: Endocannabinoids; Humans; Memory Disorders; Methamphetamine; Morphine; Morphine Dependence | 2022 |
Significance of protein kinase C in the neuropsychotoxicity induced by methamphetamine-like psychostimulants.
Topics: Animals; Bipolar Disorder; Central Nervous System Stimulants; Dopamine; Humans; Memory Disorders; Methamphetamine; Protein Kinase C-delta; Substance-Related Disorders | 2019 |
Chronic methamphetamine self-administration disrupts cortical control of cognition.
Topics: Amphetamine-Related Disorders; Cognition; Humans; Memory Disorders; Methamphetamine; Self Administration | 2016 |
[Molecular mechanism for methamphetamine-induced memory impairment].
Topics: Animals; Antipsychotic Agents; Central Nervous System Stimulants; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Humans; Memory Disorders; Methamphetamine; Mice; Mitogen-Activated Protein Kinase 3; Psychoses, Substance-Induced; Rats; Receptors, GABA; Substance-Related Disorders | 2010 |
Drug-related decrease in neuropsychological functions of abstinent drug users.
Topics: Alcoholism; Amphetamine-Related Disorders; Cannabis; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Drug Users; Hallucinogens; Heroin Dependence; Humans; Marijuana Abuse; Memory Disorders; Methadone; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Opioid-Related Disorders; Psychomotor Performance; Recognition, Psychology; Substance-Related Disorders; Verbal Behavior | 2011 |
74 other study(ies) available for methamphetamine and Memory Disorders
| Article | Year |
|---|---|
Neuronal growth and synaptogenesis are inhibited by prenatal methamphetamine exposure leading to memory impairment in adolescent and adult mice.
Topics: Aging; Animals; Female; Memory Disorders; Methamphetamine; Mice; Neurons; Pregnancy; Prenatal Exposure Delayed Effects; Synapses | 2021 |
Voluntary oral methamphetamine increases memory deficits and contextual sensitization during abstinence associated with decreased PKMζ and increased κOR in the hippocampus of female mice.
Topics: Administration, Oral; Amphetamine-Related Disorders; Animals; Behavior, Animal; Central Nervous System Stimulants; Female; Hippocampus; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Methamphetamine; Mice; Mice, Inbred C57BL; Protein Kinase C; Receptors, Opioid, kappa; Sex Factors; Spatial Memory | 2021 |
Implication of thyroid hormone receptors in methamphetamine neurocognitive effects.
Topics: Animals; Male; Memory Disorders; Methamphetamine; Rats; Rats, Wistar; Receptors, Thyroid Hormone; RNA, Messenger; Thyroid Hormones | 2022 |
Terminalia chebula extracts ameliorate methamphetamine-induced memory deficits via activating the ERK and Nrf2 pathway.
Topics: Animals; Memory Disorders; Methamphetamine; Mice; NF-E2-Related Factor 2; Plant Extracts; Terminalia | 2022 |
Effects of Moderate-Intensity Interval Training on Gene Expression and Antioxidant Status in the Hippocampus of Methamphetamine-Dependent Rats.
Topics: alpha-Synuclein; Animals; Antioxidants; Cyclin-Dependent Kinase 5; Gene Expression; Hippocampus; Male; Memory Disorders; Methamphetamine; Rats; Rats, Wistar | 2022 |
Erythropoietin improve spatial memory impairment following methamphetamine neurotoxicity by inhibition of apoptosis, oxidative stress and neuroinflammation in CA1 area of hippocampus.
Topics: Animals; Apoptosis; Erythropoietin; Hippocampus; Male; Memory Disorders; Methamphetamine; Neuroinflammatory Diseases; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Rats; Rats, Wistar; Spatial Memory | 2022 |
5-HT5A Receptor Antagonist ASP5736 Ameliorates Several Abnormal Behaviors in an Fmr1-Targeted Transgenic Male Rat Model of Fragile X Syndrome.
Topics: Animals; Disease Models, Animal; Fragile X Mental Retardation Protein; Fragile X Syndrome; Guanidines; Isoquinolines; Male; Memory Disorders; Methamphetamine; Mice; Mice, Knockout; Phencyclidine; Rats; Rats, Transgenic; Receptors, Serotonin; Scopolamine; Serotonin; Serotonin Antagonists | 2022 |
Perirhinal to prefrontal circuit in methamphetamine induced recognition memory deficits.
Topics: Animals; Memory Disorders; Methamphetamine; Prefrontal Cortex; Rats; Recognition, Psychology; Visual Perception | 2023 |
Methamphetamine administration impairs behavior, memory and underlying signaling pathways in the hippocampus.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Gliosis; Hippocampus; Long-Term Potentiation; Male; Memory Disorders; Methamphetamine; Rats; Rats, Sprague-Dawley; Signal Transduction; Spatial Memory; Synaptic Transmission | 2020 |
Neuroprotective effect of chronic administration of cannabidiol during the abstinence period on methamphetamine-induced impairment of recognition memory in the rats.
Topics: Animals; Cannabidiol; Infusions, Intraventricular; Male; Maze Learning; Memory Disorders; Methamphetamine; Neuroprotective Agents; Rats; Recognition, Psychology | 2020 |
Neurochemical and behavioral comparisons of contingent and non-contingent methamphetamine exposure following binge or yoked long-access self-administration paradigms.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Central Nervous System Stimulants; Cognition; Dopamine; Dopamine Plasma Membrane Transport Proteins; Hippocampus; Hydroxyindoleacetic Acid; Male; Maze Learning; Memory Disorders; Methamphetamine; Rats; Rats, Wistar; Self Administration | 2020 |
The consequences of regular methamphetamine use in Tehran: qualitative content analysis.
Topics: Adult; Amphetamine-Related Disorders; Feeding and Eating Disorders; Female; Hallucinations; Health Status; Humans; Interpersonal Relations; Iran; Libido; Male; Memory Disorders; Mental Health; Methamphetamine; Risk-Taking; Socioeconomic Factors; Young Adult | 2020 |
Partial MHC/neuroantigen peptide constructs attenuate methamphetamine-seeking and brain chemokine (C-C motif) ligand 2 levels in rats.
Topics: Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; Chemokine CCL2; Disease Models, Animal; Drug-Seeking Behavior; Extinction, Psychological; Immunotherapy; Male; Memory Disorders; Methamphetamine; Neuroprotective Agents; Rats, Inbred Lew; Recombinant Fusion Proteins; Self Administration; Substance-Related Disorders | 2020 |
Melatonin reverts methamphetamine-induced learning and memory impairments and hippocampal alterations in mice.
Topics: Animals; Central Nervous System Stimulants; Cognition; Hippocampus; Male; Maze Learning; Melatonin; Memory; Memory Disorders; Methamphetamine; Mice; Mice, Inbred ICR; Neurons | 2021 |
Resveratrol attenuates methamphetamine-induced memory impairment via inhibition of oxidative stress and apoptosis in mice.
Topics: Animals; Apoptosis; Kelch-Like ECH-Associated Protein 1; Memory Disorders; Methamphetamine; Mice; Molecular Docking Simulation; NF-E2-Related Factor 2; Oxidative Stress; Resveratrol | 2021 |
Electroacupuncture alleviates spatial memory deficits in METH withdrawal mice by enhancing astrocyte-mediated glutamate clearance in the dCA1.
Topics: Amphetamine-Related Disorders; Animals; Astrocytes; Electroacupuncture; Glutamic Acid; Male; Memory Disorders; Methamphetamine; Mice; Neurons; Spatial Memory | 2022 |
Melatonin protects against methamphetamine-induced Alzheimer's disease-like pathological changes in rat hippocampus.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Central Nervous System Stimulants; Cognitive Dysfunction; Hippocampus; Learning Disabilities; Male; Maze Learning; Melatonin; Memory Disorders; Methamphetamine; Neuroprotective Agents; Rats; Rats, Wistar | 2021 |
Repeated methamphetamine and modafinil induce differential cognitive effects and specific histone acetylation and DNA methylation profiles in the mouse medial prefrontal cortex.
Topics: Acetylation; Animals; Central Nervous System Stimulants; Cognition; DNA Methylation; Histones; Male; Memory Disorders; Methamphetamine; Mice, Inbred C57BL; Modafinil; Prefrontal Cortex; Recognition, Psychology | 2018 |
A Single High Dose of Methamphetamine Reduces Monoamines and Impairs Egocentric and Allocentric Learning and Memory in Adult Male Rats.
Topics: Animals; Biogenic Monoamines; Body Temperature; Central Nervous System Stimulants; Disease Models, Animal; Male; Maze Learning; Memory Disorders; Methamphetamine; Rats; Rats, Sprague-Dawley; Spatial Navigation; Statistics, Nonparametric; Time Factors | 2018 |
The inhibitory effect of levo-tetrahydropalmatine on the methamphetamine-induced spatial memory impairment in mice.
Topics: Animals; Berberine Alkaloids; Central Nervous System Stimulants; Male; Memory Disorders; Methamphetamine; Mice; Spatial Learning; Spatial Memory | 2018 |
Exposure to far-infrared rays attenuates methamphetamine-induced recognition memory impairment via modulation of the muscarinic M1 receptor, Nrf2, and PKC.
Topics: Animals; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Memory Disorders; Methamphetamine; Mice, Knockout; NF-E2-Related Factor 2; Protein Kinase C-delta; Receptor, Muscarinic M1; Up-Regulation | 2018 |
Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.
Topics: Animals; Brain; Brain-Derived Neurotrophic Factor; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Central Nervous System Stimulants; Female; HIV Envelope Protein gp120; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; Memory Disorders; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Growth Factors; Neurons; Synapses; Synapsins; Synaptic Transmission; tat Gene Products, Human Immunodeficiency Virus | 2018 |
Chemogenetic activation of the perirhinal cortex reverses methamphetamine-induced memory deficits and reduces relapse.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Cues; Disease Models, Animal; Genetic Techniques; Male; Memory Disorders; Methamphetamine; Perirhinal Cortex; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Recurrence | 2018 |
Effects of intrastriatal dopamine D1 or D2 antagonists on methamphetamine-induced egocentric and allocentric learning and memory deficits in Sprague-Dawley rats.
Topics: Animals; Central Nervous System Stimulants; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Egocentrism; Injections, Intraventricular; Male; Maze Learning; Memory Disorders; Methamphetamine; Neostriatum; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2019 |
Thyroid hormone treatment alleviates the impairments of neurogenesis, mitochondrial biogenesis and memory performance induced by methamphetamine.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Cognition; Cognition Disorders; Doublecortin Protein; Hippocampus; Inflammation; Male; Memory Disorders; Methamphetamine; Neurogenesis; Organelle Biogenesis; Psychomotor Performance; Rats; Rats, Wistar; Reelin Protein; Synapses; Thyroid Hormones; Thyroxine; Triiodothyronine | 2019 |
The Neuroprotective Effect of L-Stepholidine on Methamphetamine-Induced Memory Deficits in Mice.
Topics: Animals; Berberine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Locomotion; Male; Memory Disorders; Methamphetamine; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Random Allocation | 2019 |
Partial MHC/neuroantigen peptide constructs: a potential neuroimmune-based treatment for methamphetamine addiction.
Topics: Animals; Antigens; Cognition; Cytokines; Major Histocompatibility Complex; Male; Memory Disorders; Methamphetamine; Mice; Mice, Inbred C57BL; Neuropeptides; Recombinant Proteins; Substance-Related Disorders | 2013 |
Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex.
Topics: Adenosine A2 Receptor Antagonists; Animals; Cognition; Cognition Disorders; Disease Models, Animal; Donepezil; Dopamine; Indans; Male; Memory Disorders; Memory, Short-Term; Methamphetamine; Oxidopamine; Piperidines; Prefrontal Cortex; Purines; Rats; Rats, Sprague-Dawley | 2013 |
Impaired memory and reduced sensitivity to the circadian period lengthening effects of methamphetamine in mice selected for high methamphetamine consumption.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Circadian Rhythm; Drug-Seeking Behavior; Female; Genetic Predisposition to Disease; Hippocampus; Male; Memory Disorders; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Motor Activity; Receptors, AMPA; Self Administration; Species Specificity | 2013 |
Modafinil restores methamphetamine induced object-in-place memory deficits in rats independent of glutamate N-methyl-D-aspartate receptor expression.
Topics: Animals; Benzhydryl Compounds; Brain; Gene Expression Regulation; Male; Memory Disorders; Methamphetamine; Modafinil; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate | 2014 |
Modafinil improves methamphetamine-induced object recognition deficits and restores prefrontal cortex ERK signaling in mice.
Topics: Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Exploratory Behavior; Extracellular Signal-Regulated MAP Kinases; Hippocampus; Male; MAP Kinase Signaling System; Memory Disorders; Methamphetamine; Mice, Inbred C57BL; Modafinil; Motor Activity; Neuropsychological Tests; Nootropic Agents; Nucleus Accumbens; Phosphorylation; Prefrontal Cortex; Recognition, Psychology; Substance Withdrawal Syndrome; Visual Perception | 2014 |
Depression and executive dysfunction contribute to a metamemory deficit among individuals with methamphetamine use disorders.
Topics: Adult; Amphetamine-Related Disorders; Case-Control Studies; Cognition Disorders; Depression; Depressive Disorder, Major; Executive Function; Female; Humans; Learning; Male; Memory Disorders; Mental Recall; Methamphetamine; Middle Aged | 2015 |
Serotonergic impairment and memory deficits in adolescent rats after binge exposure of methylone.
Topics: Animals; Corpus Striatum; Designer Drugs; Dopamine Plasma Membrane Transport Proteins; Frontal Lobe; Gliosis; Hippocampus; Male; Maze Learning; Memory Disorders; Methamphetamine; Neurotoxicity Syndromes; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT2A; Serotonergic Neurons; Serotonin Plasma Membrane Transport Proteins; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase | 2014 |
The disruptive effects of methamphetamine on delayed-matching-to-sample performance reflect proactive interference and are reduced by SCH23390.
Topics: Amphetamine-Related Disorders; Animals; Benzazepines; Central Nervous System Stimulants; Disease Models, Animal; Dopamine Antagonists; Male; Memory Disorders; Memory, Short-Term; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 2015 |
Memory impairment and alterations in prefrontal cortex gamma band activity following methamphetamine sensitization.
Topics: Animals; Behavior, Addictive; Central Nervous System Stimulants; Cognition; Electroencephalography; Male; Memory Disorders; Methamphetamine; Motor Activity; Neurons; Prefrontal Cortex; Rats; Recognition, Psychology; Stereotyped Behavior | 2015 |
Failure to Recognize Novelty after Extended Methamphetamine Self-Administration Results from Loss of Long-Term Depression in the Perirhinal Cortex.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Cycloserine; Excitatory Amino Acid Agents; Long-Term Synaptic Depression; Male; Memory Disorders; Methamphetamine; Phenols; Piperidines; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Self Administration; Tissue Culture Techniques | 2015 |
Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits.
Topics: Administration, Oral; Aging; Animals; CA1 Region, Hippocampal; Dentate Gyrus; Drinking Water; Exploratory Behavior; Male; Memory Disorders; Methamphetamine; Nicotine; Nicotinic Agonists; Nootropic Agents; Rats, Sprague-Dawley; Receptors, Nicotinic; Recognition, Psychology; Serotonin Plasma Membrane Transport Proteins; Temporal Lobe | 2015 |
Memory disrupting effects of nonmuscle myosin II inhibition depend on the class of abused drug and brain region.
Topics: Analysis of Variance; Anesthetics, Local; Animals; Brain; Central Nervous System Stimulants; Cocaine; Conditioning, Operant; Dendritic Spines; Green Fluorescent Proteins; Heterocyclic Compounds, 4 or More Rings; Memory Disorders; Mental Recall; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microinjections; Morphine Derivatives; Myosin Type II | 2017 |
Blocking histamine H(1) improves learning and mnemonic dysfunction in mice with social isolation plus repeated methamphetamine injection.
Topics: Animals; Avoidance Learning; Fear; Histamine H1 Antagonists; Learning Disabilities; Male; Maze Learning; Memory Disorders; Methamphetamine; Mice; Mice, Inbred ICR; Reflex, Startle; Social Isolation | 2008 |
Prospective memory impairment in former users of methamphetamine.
Topics: Cognition; Female; Humans; Male; Memory Disorders; Methamphetamine; Neuropsychological Tests; Substance-Related Disorders; Task Performance and Analysis | 2009 |
Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals.
Topics: Adult; Amphetamine-Related Disorders; Brain; Central Nervous System Stimulants; Electroencephalography; Female; Humans; Male; Memory; Memory Disorders; Methamphetamine; Neuropsychological Tests; Substance Withdrawal Syndrome; Theta Rhythm | 2009 |
Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment.
Topics: Animals; Brain; Cognition; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Hippocampus; Male; Memory Disorders; Methamphetamine; Mice; Mice, Inbred ICR; Nootropic Agents; Prefrontal Cortex; Recognition, Psychology; Serotonin; Silybin; Silymarin | 2010 |
Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence.
Topics: Adult; Amphetamine-Related Disorders; Case-Control Studies; Cognition Disorders; Executive Function; Female; Humans; Longitudinal Studies; Male; Memory Disorders; Methamphetamine; Neuropsychological Tests; Time Factors | 2010 |
Memantine is a useful drug to prevent the spatial and non-spatial memory deficits induced by methamphetamine in rats.
Topics: Animals; Body Temperature; Dopamine Uptake Inhibitors; Hippocampus; Male; Maze Learning; Memantine; Memory; Memory Disorders; Methamphetamine; Nicotinic Antagonists; Rats; Rats, Long-Evans; Receptors, Nicotinic | 2010 |
Impairments of facial emotion recognition and theory of mind in methamphetamine abusers.
Topics: Adult; Amphetamine-Related Disorders; Emotions; Facial Expression; Female; Humans; Intelligence Tests; Male; Memory Disorders; Methamphetamine; Middle Aged; Neuropsychological Tests; Photic Stimulation; Recognition, Psychology; Theory of Mind | 2011 |
Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5.
Topics: Allosteric Regulation; Animals; Hippocampus; Male; Memory; Memory Disorders; Methamphetamine; Rats; Rats, Long-Evans; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Recognition, Psychology; Self Administration | 2011 |
Nicotine ameliorates impairment of working memory in methamphetamine-treated rats.
Topics: Animals; Attention; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Food Deprivation; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Methamphetamine; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Spatial Behavior; Sympathomimetics; Time Factors | 2011 |
Misremembering future intentions in methamphetamine-dependent individuals.
Topics: Adult; Amphetamine-Related Disorders; Female; Humans; Intention; Male; Memory Disorders; Methamphetamine; Middle Aged; Neuropsychological Tests; Regression Analysis | 2011 |
Levels of neural progenitors in the hippocampus predict memory impairment and relapse to drug seeking as a function of excessive methamphetamine self-administration.
Topics: Adult Stem Cells; Analysis of Variance; Animals; Behavior, Addictive; Bromodeoxyuridine; Caspase 3; Central Nervous System Stimulants; Conditioning, Operant; Extinction, Psychological; Hippocampus; Ki-67 Antigen; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Methamphetamine; Neurogenesis; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Reinforcement Schedule; Self Administration; Space Perception; Time Factors | 2012 |
Cognitive and subjective effects of mephedrone and factors influencing use of a 'new legal high'.
Topics: Case-Control Studies; Central Nervous System Stimulants; Executive Function; Female; Humans; Male; Memory Disorders; Methamphetamine; Psychomotor Disorders; Speech Disorders; Substance-Related Disorders; Young Adult | 2012 |
Methamphetamine mimics the neurochemical profile of aging in rats and impairs recognition memory.
Topics: Age Factors; Aging; Animals; Behavior, Animal; Brain; Brain Chemistry; Dopamine; Exploratory Behavior; Hydroxyindoleacetic Acid; Male; Memory Disorders; Methamphetamine; Rats; Rats, Wistar; Recognition, Psychology; Serotonin; Time Factors | 2012 |
Sex differences in escalation of methamphetamine self-administration: cognitive and motivational consequences in rats.
Topics: Animals; Cognition Disorders; Conditioning, Operant; Drug-Seeking Behavior; Female; Male; Memory Disorders; Methamphetamine; Motivation; Rats; Rats, Long-Evans; Recognition, Psychology; Self Administration; Sex Factors; Time Factors | 2012 |
The evaluation of AZ66, an optimized sigma receptor antagonist, against methamphetamine-induced dopaminergic neurotoxicity and memory impairment in mice.
Topics: Analysis of Variance; Animals; Avoidance Learning; Benzothiazoles; Body Temperature; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Male; Memory Disorders; Methamphetamine; Mice; Neurotoxicity Syndromes; Neurotransmitter Agents; Piperazines; Protein Binding; Receptors, sigma; Recognition, Psychology; Tritium | 2013 |
Mephedrone in adolescent rats: residual memory impairment and acute but not lasting 5-HT depletion.
Topics: Animals; Corpus Striatum; Designer Drugs; Dopamine; Hippocampus; Male; Maze Learning; Memory Disorders; Memory, Long-Term; Methamphetamine; Motor Activity; Rats; Rats, Wistar; Serotonin; Weight Gain | 2012 |
Methamphetamine-induced changes in the mice hippocampal neuropeptide Y system: implications for memory impairment.
Topics: Animals; Central Nervous System Stimulants; Hippocampus; Male; Memory Disorders; Methamphetamine; Mice; Mice, Inbred C57BL; Neuropeptide Y; Proto-Oncogene Proteins c-akt; Receptors, Neuropeptide Y; Signal Transduction; TOR Serine-Threonine Kinases | 2012 |
Long-term cognitive and neurochemical effects of "bath salt" designer drugs methylone and mephedrone.
Topics: Animals; Anxiety; Brain; Depression; Designer Drugs; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Hindlimb Suspension; Male; Maze Learning; Memory Disorders; Methamphetamine; Mice; Mice, Inbred C57BL; Norepinephrine; Radioligand Assay; Rats; Rats, Wistar; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2013 |
Manganese-based complexes of radical scavengers as neuroprotective agents.
Topics: Animals; Antioxidants; Brain; Brain Ischemia; Dopamine; Flavonoids; Free Radical Scavengers; In Vitro Techniques; Learning; Lipid Peroxidation; Manganese; Memory Disorders; Methamphetamine; Mice; Motor Activity; Neurodegenerative Diseases; Neuroprotective Agents; Organometallic Compounds; Superoxide Dismutase; Tacrine | 2003 |
Neurotoxic methamphetamine regimen severely impairs recognition memory in rats.
Topics: Animals; Brain; Carrier Proteins; Dopamine Plasma Membrane Transport Proteins; Male; Membrane Glycoproteins; Membrane Transport Proteins; Memory Disorders; Methamphetamine; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Serotonin Plasma Membrane Transport Proteins | 2003 |
Structural abnormalities in the brains of human subjects who use methamphetamine.
Topics: Adult; Amphetamine-Related Disorders; Brain; Brain Mapping; Cerebral Cortex; Dominance, Cerebral; Female; Gyrus Cinguli; Hippocampus; Humans; Hypertrophy; Image Processing, Computer-Assisted; Limbic System; Magnetic Resonance Imaging; Male; Memory Disorders; Methamphetamine; Myelin Sheath | 2004 |
Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity.
Topics: Analysis of Variance; Animals; Behavior, Animal; Body Temperature; Cell Count; Cocaine; Dextroamphetamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Fluoresceins; Male; Memory Disorders; Methamphetamine; Neurons; Neuropsychological Tests; Organic Chemicals; p-Chloroamphetamine; Parietal Lobe; Protein Binding; Radioligand Assay; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Serotonin; Serotonin Agents | 2005 |
Learning in the Place navigation task, not the New-learning task, is altered by prenatal methamphetamine exposure.
Topics: Amphetamine-Related Disorders; Animals; Brain; Central Nervous System Stimulants; Disease Models, Animal; Female; Learning Disabilities; Male; Maze Learning; Memory; Memory Disorders; Methamphetamine; Orientation; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Sex Characteristics; Sex Factors | 2005 |
Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of mice.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Blotting, Western; Dopamine Uptake Inhibitors; Drug Administration Schedule; Drug Interactions; Enzyme Activation; Exploratory Behavior; Male; Memory Disorders; Methamphetamine; Mice; Mice, Inbred ICR; Mitogen-Activated Protein Kinase 1; Motor Activity; Neuropsychological Tests; Phosphorylation; Prefrontal Cortex; Time Factors | 2006 |
The effects of chronic administration of quetiapine on the methamphetamine-induced recognition memory impairment and dopaminergic terminal deficit in rats.
Topics: Animals; Antipsychotic Agents; Biomarkers; Body Temperature; Central Nervous System Stimulants; Dibenzothiazepines; Dopamine; Exploratory Behavior; Immunohistochemistry; Male; Memory; Memory Disorders; Methamphetamine; Presynaptic Terminals; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Tyrosine 3-Monooxygenase | 2006 |
Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users.
Topics: Amphetamine-Related Disorders; Cadaver; Cognition Disorders; Frontal Lobe; HIV Seropositivity; Humans; Interneurons; Memory Disorders; Methamphetamine; Nerve Degeneration; Severity of Illness Index | 2006 |
Memory impairment in methamphetamine dependent patients.
Topics: Adult; Amphetamine-Related Disorders; Case-Control Studies; Central Nervous System Stimulants; Humans; Male; Matched-Pair Analysis; Memory; Memory Disorders; Methamphetamine; Neuropsychological Tests; Pattern Recognition, Visual; Verbal Learning | 2007 |
Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Blotting, Western; Central Nervous System Stimulants; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Haloperidol; Hippocampus; Injections, Subcutaneous; Male; Maze Learning; Memory Disorders; Methamphetamine; Mitogen-Activated Protein Kinase 3; Phosphorylation; Rats; Rats, Wistar; Time Factors | 2007 |
Neonatal (+)-methamphetamine increases brain derived neurotrophic factor, but not nerve growth factor, during treatment and results in long-term spatial learning deficits.
Topics: Animals; Animals, Newborn; Brain-Derived Neurotrophic Factor; Corticosterone; Female; Hippocampus; Hypothalamus; Learning; Male; Maze Learning; Memory Disorders; Methamphetamine; Nerve Growth Factors; Rats; Rats, Sprague-Dawley; Spatial Behavior; Time Factors | 2007 |
Age-dependent effects of neonatal methamphetamine exposure on spatial learning.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Body Weight; Central Nervous System Stimulants; Female; Male; Maze Learning; Memory Disorders; Methamphetamine; Rats; Rats, Sprague-Dawley; Spatial Behavior; Swimming; Time | 2007 |
Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice.
Topics: Animals; Behavior, Animal; Clozapine; Dose-Response Relationship, Drug; Exploratory Behavior; Haloperidol; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Memory Disorders; Methamphetamine; Mice; Mice, Inbred ICR; Minocycline; Mitogen-Activated Protein Kinase 3; Motor Activity; Neuroprotective Agents; Phosphorylation; Time Factors | 2008 |
Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory.
Topics: Animals; Central Nervous System Stimulants; Fluoresceins; Gliosis; Glutamic Acid; Hippocampus; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Methamphetamine; Nerve Degeneration; Organic Chemicals; Protein Subunits; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission; Up-Regulation | 2007 |
Adult learning deficits after neonatal exposure to D-methamphetamine: selective effects on spatial navigation and memory.
Topics: Aging; Animals; Animals, Newborn; Cues; Dose-Response Relationship, Drug; Learning Disabilities; Maze Learning; Memory; Memory Disorders; Methamphetamine; Motor Activity; Rats; Rats, Sprague-Dawley; Space Perception | 2000 |
Chroman amide 12P inhibition of lipid peroxidation and protection against learning and memory impairment.
Topics: Amnesia; Animals; Antioxidants; Brain; Chromans; Cognition Disorders; Dopamine Agents; Drug Interactions; Free Radical Scavengers; Indoles; Learning Disabilities; Lipid Peroxidation; Male; Maze Learning; Memory Disorders; Methamphetamine; Mice; Mice, Inbred ICR; Motor Activity; Scopolamine | 2000 |
Cognitive performance of current methamphetamine and cocaine abusers.
Topics: Adult; Amphetamine-Related Disorders; Cocaine; Cognition Disorders; Female; Humans; Male; Memory Disorders; Methamphetamine; Psychiatric Status Rating Scales; Reaction Time | 2002 |
Effect of FR121196, a novel cognitive enhancer, on the memory impairment of rats in passive avoidance and radial arm maze tasks.
Topics: Aging; Animals; Avoidance Learning; Brain; Choline O-Acetyltransferase; Cognition Disorders; Dementia; Discrimination Learning; Disease Models, Animal; Male; Memory Disorders; Methamphetamine; Motor Activity; Physostigmine; Piperazines; Rats; Rats, Inbred F344; Rats, Wistar; Scopolamine; Sulfonamides | 1992 |